Tahmeed Contractor, MD
Cardiovascular Disease (Cardiology) · Reedsburg
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
Offices
1 location · University of Wisconsin Medical Foundation Inc · 2,537 clinicians in this group
Looking this up.
Hospitals listed: Unitypoint Health - Meriter · University of Wi Hospitals & Clinics Authority. That is not proof they admit you there this week.
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Contractor’s office at (608) 768-3900 to ask if they take your plan before you enroll.
California Medical Board record
Licence A127103 · Current
Licensed to practise in California · since 2013 · expires 2027-04-30 · Maharashtra University of Health Sciences, Lokmanya Tilak Municipal Medical College.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
2 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Unitypoint Health - MeriterMadison, WIAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Unitypoint Health, which runs 29 hospitals in 3 statesPatients rate it 4 of 5 · 76% would definitely recommend itOverall rating: 5 of 5 starsBetter than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.361, Oct 2024 – Sep 2025Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.313, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.669, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0.163, Oct 2024 – Sep 2025
- University of Wi Hospitals & Clinics AuthorityMadison, WIAcute Care Hospital · Government - Hospital District or Authority · Has an emergency departmentPart of UW Health, which runs 3 hospitals in 2 statesHome of University of Wisconsin Carbone Cancer Center, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 82% would definitely recommend itOverall rating: 5 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 4.93 (3.64 to 6.22) · 5,729 cases, Jul 2022 – Jun 2024Worse than the national rate — SSI - Colon Surgery: 1.52, Oct 2024 – Sep 2025Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.485, Oct 2024 – Sep 2025Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.593, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.613, Oct 2024 – Sep 2025
See every measure and the patient survey for Unitypoint Health - Meriter
Behind the star rating — Deaths: 3 better, 4 the same, 0 worse of 7 measures. Safety: 1 better, 6 the same, 0 worse of 7 measures. Readmissions: 1 better, 6 the same, 2 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.361 | Better | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.313 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.669 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.163 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.03 (0.08 to 1.99) · 1,217 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.83 (0.48 to 1.17) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 150.42 (93.96 to 206.88) · 40 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 7.7 · 133 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11 · 127 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 10.4 · 486 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 12.9 · 468 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.6 · 200 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3 · 2,794 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.2 (0 to 0.4) · 6,380 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.38 (0.18 to 0.58) · 6,401 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 2.31 (0.16 to 4.45) · 997 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.56 (0 to 3.24) · 254 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.31 (0.79 to 3.83) · 960 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 6.4 (0 to 14.8) · 256 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 4.94 (1.06 to 8.82) · 231 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.6 (0.14 to 3.06) · 248 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.5 (0 to 1.15) · 5,150 cases | No different | Jul 2022 – Jun 2024 |
| SSI - Abdominal HysterectomyInfections | 2.212 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.609 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 12.8 · 120 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22.6 · 680 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | -27.4 · 106 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 13.5 · 579 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 9.6 · 501 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 17.3 · 585 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.2 (3.3 to 8.1) · 39 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 10.9 (7.4 to 15.9) · 39 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.5 · 225 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 14 (11.3 to 17.7) · 2,010 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1.1 (0.9 to 1.3) · 962 cases | No different | Jan 2024 – Dec 2024 |
What patients said (482 patients answered, 21% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 3 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 4 |
| Recommend hospital | 4 |
| Room was "always" clean | 73% |
| Nurses "always" communicated well | 80% |
| Doctors "always" communicated well | 78% |
| Staff "always" explained | 64% |
| Yes, staff "did" give patients this information | 88% |
| Yes, staff "did" give patients information about help after discharge | 87% |
| Doctors "always" explained things so they could understand | 73% |
| Doctors "always" listened carefully | 76% |
| Doctors "always" treated them with courtesy and respect | 86% |
| Patients who gave a rating of "9" or "10" (high) | 73% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 76% |
| Nurses "always" treated them with courtesy and respect | 89% |
| "Always" quiet at night | 61% |
| "YES", patients would definitely recommend the hospital | 76% |
| Staff "always" explained possible side effects | 52% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
See every measure and the patient survey for University of Wi Hospitals & Clinics Authority
Behind the star rating — Deaths: 3 better, 5 the same, 0 worse of 8 measures. Safety: 2 better, 6 the same, 0 worse of 8 measures. Readmissions: 1 better, 9 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 4.93 (3.64 to 6.22) · 5,729 cases | Worse | Jul 2022 – Jun 2024 |
| SSI - Colon SurgeryInfections | 1.52 | Worse | Oct 2024 – Sep 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.485 | Better | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.593 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.613 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.41 (0.74 to 2.09) · 4,035 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.04 (0.87 to 1.22) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 181.11 (148.97 to 213.24) · 341 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.1 · 173 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6.8 · 126 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11.6 · 365 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 8.5 · 619 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 9.3 · 582 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.7 · 523 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.5 · 6,380 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.2 (0.04 to 0.37) · 14,967 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.23 (0.06 to 0.39) · 16,098 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.8 (0.76 to 2.84) · 3,095 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.56 (1.56 to 3.56) · 4,743 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 9.25 (6.19 to 12.31) · 2,990 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 3.89 (2.03 to 5.75) · 3,097 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 2 (0.84 to 3.16) · 1,690 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.71 (0.33 to 1.09) · 13,588 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.5 · 194 cases | None | Apr 2023 – Mar 2025 |
| MRSA BacteremiaInfections | 0.707 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.405 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 13.9 · 487 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20 · 939 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | -2 · 407 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -5.7 · 700 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 7.6 · 592 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.5 · 718 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 6.5 (5.4 to 7.9) · 1,266 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 9.6 (8.2 to 11.4) · 1,266 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.3 · 203 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10.8 · 170 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 21.6 · 234 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.2 (10.2 to 14.7) · 7,655 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.7 to 1) · 2,865 cases | No different | Jan 2024 – Dec 2024 |
What patients said (3,209 patients answered, 34% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 5 |
| Overall hospital rating | 4 |
| Quietness | 3 |
| Recommend hospital | 5 |
| Room was "always" clean | 70% |
| Nurses "always" communicated well | 81% |
| Doctors "always" communicated well | 79% |
| Staff "always" explained | 62% |
| Yes, staff "did" give patients this information | 91% |
| Yes, staff "did" give patients information about help after discharge | 91% |
| Doctors "always" explained things so they could understand | 73% |
| Doctors "always" listened carefully | 79% |
| Doctors "always" treated them with courtesy and respect | 86% |
| Patients who gave a rating of "9" or "10" (high) | 77% |
| Staff "always" explained new medications | 74% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 80% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 57% |
| "YES", patients would definitely recommend the hospital | 82% |
| Staff "always" explained possible side effects | 49% |
| Yes, staff "did" give patients information about possible symptoms | 91% |
Original Medicare doctor bills
$253,351
Medicare paid this office $253,351 for 586 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Long return visit (40+ min) | 382 | $79,834 | $134 |
| Comprehensive electrophysiologic evaluation with catheter destruction of abnormality causing atrial fibrillation (uncoordinated contraction of upper chambers of heart) by pulmonary vein isolation | 39 | $28,105 | $721 |
| Repair of left upper heart chamber with implant with review by radiologist | 37 | $22,892 | $602 |
| New patient visit (60+ min) | 80 | $13,546 | $169 |
| Evaluation of cardiac rhythm monitor system, remote up to 30 days | 34 | $13,357 | $86 |
See all 17 services
| Long return visit (40+ min) | 382 | $79,834 | $134 |
| Comprehensive electrophysiologic evaluation with catheter destruction of abnormality causing atrial fibrillation (uncoordinated contraction of upper chambers of heart) by pulmonary vein isolation | 39 | $28,105 | $721 |
| Repair of left upper heart chamber with implant with review by radiologist | 37 | $22,892 | $602 |
| New patient visit (60+ min) | 80 | $13,546 | $169 |
| Evaluation of cardiac rhythm monitor system, remote up to 30 days | 34 | $13,357 | $86 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 75 | $10,853 | $137 |
| Insertion of implantable defibrillator system | 15 | $10,473 | $698 |
| Destruction of tissue of upper heart chamber through tube to treat abnormal heart rhythm | 22 | $7,590 | $237 |
| Comprehensive electrophysiologic evaluation with catheter destruction of abnormality of upper chamber of heart causing supraventricular tachycardia (rapid heart rate) | 11 | $6,905 | $628 |
| Return visit (30+ min) | 58 | $6,411 | $105 |
| Insertion of left lower heart electrode for pacemaker or defibrillator | 13 | $4,646 | $357 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | 129 | $3,654 | $17 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | 71 | $3,506 | $28 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 58 | $1,892 | $22 |
| Programming of dual lead pacemaker system | 30 | $1,847 | $58 |
| Programming of multiple lead implantable defibrillator system | 12 | $1,084 | $83 |
| Programming of heart rhythm stimulation after drug infusion | 15 | $801 | $53 |
Procedures Medicare counted
| Pacemaker insertion or repair | 41 | More than 85% of doctors who do this |
Who their Medicare patients are
586 Original Medicare patients in 2024. Average age 75 · Under 65 11% · 85 and older 19% · Women 40% · Also on Medicaid 31% · Health risk score 2.03. Above the middle of the specialty; the typical clinical cardiac electrophysiology clinician is at 1.8.
Conditions among them: High blood pressure 75% · Atrial fibrillation 74% · Heart failure 59% · Coronary heart disease 54% · Diabetes 42% · Chronic kidney disease 36% · COPD 19% · Depression 19% · Cancer 15% · Stroke 13% · Dementia 9%.
The office billed $1,036,452, Medicare allowed $331,178 and paid $253,351; for 1,784 services of 67 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 586 | 1,784 | 75 | 2.03 | $1,036,452 | $253,351 |
| 2023 | 542 | 1,784 | 75 | 2.12 | $926,255 | $232,534 |
| 2022 | 547 | 1,596 | 75 | 2.13 | $796,423 | $208,215 |
| 2021 | 469 | 1,246 | 73 | 2.12 | $742,805 | $204,493 |
| 2020 | 414 | 1,097 | 74 | 2.52 | $553,288 | $148,225 |
| 2019 | 415 | 1,388 | 74 | 2.49 | $656,647 | $170,182 |
| 2018 | 350 | 1,035 | 73 | 2.61 | $565,754 | $141,937 |
| 2017 | 330 | 1,069 | 73 | 2.58 | $552,255 | $143,055 |
| 2016 | 482 | 1,406 | 76 | 2.38 | $609,059 | $155,334 |
| 2015 | 240 | 565 | 77 | 2.21 | $207,805 | $55,370 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 22 services
| Long return visit (40+ min) | 280 | $58,264 | $139 |
| Comprehensive electrophysiologic evaluation with catheter destruction of abnormality causing atrial fibrillation (uncoordinated contraction of upper chambers of heart) by pulmonary vein isolation | 38 | $29,448 | $755 |
| Repair of left upper heart chamber with implant with review by radiologist | 33 | $20,390 | $618 |
| New patient visit (60+ min) | 86 | $14,350 | $167 |
| Destruction of tissue of upper heart chamber through tube to treat abnormal heart rhythm | 28 | $12,313 | $246 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 73 | $10,544 | $141 |
| Comprehensive electrophysiologic evaluation with catheter destruction of abnormality of upper chamber of heart causing supraventricular tachycardia (rapid heart rate) | 13 | $8,726 | $671 |
| Return visit (30+ min) | 75 | $7,030 | $82 |
| Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and tec | 26 | $5,015 | $43 |
| Insertion of catheters and destruction of tissue to treat abnormal heart rhythm | 14 | $4,433 | $246 |
| Insertion of permanent leadless pacemaker using imaging guidance | 12 | $4,067 | $339 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | 122 | $3,207 | $15 |
| Programming of dual lead pacemaker system | 39 | $3,182 | $66 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | 61 | $2,375 | $23 |
| Evaluation of cardiac rhythm monitor system, remote up to 30 days | 25 | $2,056 | $17 |
| Programming of multiple lead implantable defibrillator system | 19 | $2,047 | $89 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 62 | $2,019 | $20 |
| Programming of dual lead implantable defibrillator system | 20 | $1,982 | $83 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 12 | $1,350 | $96 |
| Removal of permanent pacemaker pulse generator | 12 | $1,147 | $96 |
| Programming of heart rhythm stimulation after drug infusion | 15 | $1,015 | $68 |
| Programming of cardiac rhythm monitor system | 16 | $966 | $51 |
2022: 18 services
| Return visit (30+ min) | 348 | $63,945 | $97 |
| Comprehensive electrophysiologic evaluation with catheter destruction of abnormality causing atrial fibrillation (uncoordinated contraction of upper chambers of heart) by pulmonary vein isolation | 31 | $28,435 | $917 |
| Destruction of tissue of upper heart chamber through tube to treat abnormal heart rhythm | 27 | $12,585 | $257 |
| New patient visit (60+ min) | 65 | $11,547 | $178 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 69 | $11,236 | $161 |
| Repair of left upper heart chamber with implant with review by radiologist | 17 | $11,045 | $650 |
| Insertion of implantable defibrillator system | 13 | $9,922 | $763 |
| Insertion of catheters and destruction of tissue to treat abnormal heart rhythm | 16 | $5,407 | $257 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 21 | $2,688 | $84 |
| Long return visit (40+ min) | 17 | $2,540 | $149 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | 103 | $2,308 | $16 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | 55 | $1,934 | $24 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 50 | $1,364 | $20 |
| Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and tec | 26 | $1,267 | $21 |
| Evaluation of cardiac rhythm monitor system, remote up to 30 days | 26 | $1,168 | $19 |
| Programming of heart rhythm stimulation after drug infusion | 12 | $1,119 | $86 |
| Heart rhythm review and interpretation of continous external ekg over 8-15 days | 35 | $860 | $22 |
| Heart rhythm review, and interpretation of continous external ekg over more than 48 hours up to 7 days | 13 | $233 | $18 |
2021: 19 services
| Return visit (30+ min) | 292 | $52,347 | $101 |
| Comprehensive electrophysiologic evaluation with catheter destruction of abnormality causing atrial fibrillation (uncoordinated contraction of upper chambers of heart) by pulmonary vein isolation | 36 | $35,047 | $947 |
| Destruction of tissue of upper heart chamber through tube to treat abnormal heart rhythm | 23 | $13,656 | $359 |
| Insertion of tube for 3d mapping of electrical impulses to heart muscle | 44 | $11,529 | $251 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 67 | $10,812 | $159 |
| New patient visit (60+ min) | 45 | $8,000 | $178 |
| Repair of left upper heart chamber with implant with review by radiologist | 11 | $7,332 | $667 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 43 | $6,147 | $87 |
| Ultrasound evaluation of heart blood vessel with review by radiologist | 41 | $4,111 | $98 |
| Programming of heart rhythm stimulation after drug infusion | 16 | $1,766 | $110 |
| Telephone medical discussion with physician, 11-20 minutes | 20 | $1,305 | $65 |
| Short return visit (20+ min) | 17 | $1,250 | $69 |
| Heart rhythm review and interpretation of continous external ekg over 8-15 days | 33 | $755 | $22 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | 26 | $528 | $20 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | 13 | $413 | $32 |
| Electrocardiogram (ecg) up to 30 days continuous with review and report by health care professional | 15 | $350 | $22 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 13 | $283 | $22 |
| Electrocardiogram (ecg) up to 30 days continuous with symptom monitoring, transmission and review and report by health care professional | 12 | $253 | $21 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 13 | $153 | $12 |
2020: 17 services
| Return visit (30+ min) | 194 | $25,330 | $81 |
| Comprehensive electrophysiologic evaluation with catheter destruction of abnormality causing atrial fibrillation (uncoordinated contraction of upper chambers of heart) by pulmonary vein isolation | 20 | $19,187 | $959 |
| Telephone medical discussion with physician, 11-20 minutes | 99 | $7,775 | $63 |
| Destruction of tissue of upper heart chamber through tube to treat abnormal heart rhythm | 11 | $7,279 | $364 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 42 | $7,056 | $164 |
| Insertion of tube for 3d mapping of electrical impulses to heart muscle | 27 | $6,867 | $254 |
| New patient visit (60+ min) | 40 | $6,393 | $160 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 32 | $4,421 | $87 |
| Ultrasound evaluation of heart blood vessel with review by radiologist | 28 | $3,442 | $123 |
| Short return visit (20+ min) | 50 | $2,900 | $54 |
| Programming of dual lead pacemaker system | 26 | $1,819 | $57 |
| Review and interpretation of external ekg recording for more than 48 hours up to 21 days | 62 | $1,460 | $19 |
| Programming of multiple lead implantable defibrillator system | 13 | $1,201 | $86 |
| Programming of dual lead implantable defibrillator system | 11 | $969 | $69 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 11 | $910 | $61 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 15 | $289 | $19 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | 11 | $262 | $24 |
2019: 20 services
| Return visit (30+ min) | 231 | $31,627 | $84 |
| Comprehensive electrophysiologic evaluation with catheter destruction of abnormality causing atrial fibrillation (uncoordinated contraction of upper chambers of heart) by pulmonary vein isolation | 27 | $26,120 | $933 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 58 | $9,951 | $166 |
| Insertion of tube for 3d mapping of electrical impulses to heart muscle | 34 | $8,618 | $246 |
| Destruction of tissue of upper heart chamber through tube to treat abnormal heart rhythm | 18 | $7,416 | $353 |
| New patient visit (60+ min) | 30 | $5,092 | $170 |
| Insertion of pacemaker and upper and lower heart chamber electrode | 11 | $4,690 | $426 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 33 | $4,544 | $86 |
| Ultrasound evaluation of heart blood vessel with review by radiologist | 35 | $4,317 | $120 |
| Programming of multiple lead implantable defibrillator system | 32 | $3,819 | $73 |
| Short return visit (20+ min) | 61 | $3,705 | $56 |
| New patient visit (45+ min) | 22 | $2,871 | $130 |
| Programming of dual lead pacemaker system | 39 | $2,830 | $53 |
| Programming of dual lead implantable defibrillator system | 30 | $2,708 | $68 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 138 | $2,464 | $14 |
| Programming of heart rhythm stimulation after drug infusion | 11 | $1,586 | $132 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system | 17 | $637 | $37 |
| Evaluation of cardiac rhythm monitor system, remote up to 30 days | 13 | $335 | $21 |
| Review and interpretation of external ekg recording for more than 48 hours up to 21 days | 14 | $309 | $22 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 11 | $280 | $25 |
2018: 20 services
| Return visit (30+ min) | 164 | $22,536 | $83 |
| Comprehensive electrophysiologic evaluation with catheter destruction of abnormality causing atrial fibrillation (uncoordinated contraction of upper chambers of heart) by pulmonary vein isolation | 21 | $20,193 | $878 |
| Comprehensive electrophysiologic evaluation with catheter destruction of abnormality of upper chamber of heart causing supraventricular tachycardia (rapid heart rate) | 16 | $10,853 | $678 |
| Insertion of tube for 3d mapping of electrical impulses to heart muscle | 34 | $9,476 | $263 |
| Insertion of implantable defibrillator system | 11 | $8,206 | $746 |
| Insertion of pacemaker and upper and lower heart chamber electrode | 16 | $6,793 | $425 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 32 | $5,473 | $161 |
| New patient visit (45+ min) | 39 | $5,061 | $130 |
| Short return visit (20+ min) | 82 | $4,947 | $55 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 29 | $3,247 | $108 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 27 | $3,224 | $85 |
| Ultrasound evaluation of heart blood vessel with review by radiologist | 25 | $3,077 | $118 |
| Programming of heart rhythm stimulation after drug infusion | 20 | $2,720 | $130 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 27 | $1,909 | $58 |
| New patient visit (60+ min) | 13 | $1,908 | $147 |
| New patient visit (60+ min) | 11 | $1,506 | $137 |
| Long return visit (40+ min) | 12 | $1,214 | $101 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 55 | $937 | $14 |
| Blood test, clotting time | 23 | $361 | $5 |
| Ultrasonic guidance for blood vessel access | 12 | $153 | $12 |
2017: 14 services
| Return visit (30+ min) | 186 | $30,992 | $83 |
| Comprehensive electrophysiologic evaluation with catheter destruction of abnormality causing atrial fibrillation (uncoordinated contraction of upper chambers of heart) by pulmonary vein isolation | 16 | $15,379 | $905 |
| Insertion of implantable defibrillator system | 16 | $11,514 | $720 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 71 | $11,415 | $159 |
| Comprehensive electrophysiologic evaluation with catheter destruction of abnormality of upper chamber of heart causing supraventricular tachycardia (rapid heart rate) | 15 | $10,061 | $629 |
| Insertion of tube for 3d mapping of electrical impulses to heart muscle | 23 | $8,326 | $320 |
| Insertion of pacemaker and upper and lower heart chamber electrode | 20 | $8,015 | $401 |
| New patient visit (60+ min) | 32 | $4,823 | $151 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 29 | $3,726 | $85 |
| Ultrasound evaluation of heart blood vessel with review by radiologist | 26 | $3,320 | $119 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 87 | $1,926 | $14 |
| Short return visit (20+ min) | 26 | $1,805 | $60 |
| Programming of heart rhythm stimulation after drug infusion | 11 | $1,420 | $129 |
| Blood test, clotting time | 16 | $385 | $5 |
2016: 13 services
| Return visit (30+ min) | 299 | $38,511 | $77 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 82 | $14,868 | $163 |
| Insertion of implantable defibrillator system | 16 | $11,982 | $749 |
| Comprehensive electrophysiologic evaluation with catheter destruction of abnormality of upper chamber of heart causing supraventricular tachycardia (rapid heart rate) | 16 | $11,453 | $674 |
| New patient visit (60+ min) | 66 | $10,921 | $165 |
| Programming of dual lead pacemaker system | 146 | $7,869 | $44 |
| Insertion of tube for 3d mapping of electrical impulses to heart muscle | 19 | $6,708 | $319 |
| Insertion of pacemaker and upper and lower heart chamber electrode | 15 | $6,364 | $424 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 44 | $5,730 | $83 |
| Removal and replacement of dual lead permanent pacemaker | 11 | $3,227 | $293 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 104 | $1,946 | $14 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system | 50 | $1,394 | $25 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system | 17 | $935 | $52 |
2015: 9 services
| Return visit (30+ min) | 123 | $13,343 | $88 |
| New patient visit (60+ min) | 33 | $5,450 | $165 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 25 | $4,294 | $165 |
| Long return visit (40+ min) | 24 | $3,461 | $119 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system | 78 | $2,740 | $31 |
| Programming of dual lead pacemaker system | 50 | $2,627 | $49 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 17 | $2,202 | $85 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system | 12 | $921 | $54 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 55 | $789 | $14 |
Medicaid work
$44,847 in 2024
Medicaid paid $44,847 for 551 billed services this clinician did in 2024, up to 46 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Long return visit (40+ min) | 315 | $40,151 |
| Interrogation device evaluation(s) (remote), up to 90 days; single, dual, or multiple lead pacemaker system, leadless pacemaker system, or implantable defibrillator system, remote data acquisition(s), receipt of transmissions and technician review, technical support and distribution of results | 120 | $1,786 |
| Interrogation device evaluation(s) (remote), up to 90 days; single, dual, or multiple lead implantable defibrillator system with interim analysis, review(s) and report(s) by a physician or other qualified health care professional | 65 | $1,521 |
| Interrogation device evaluation(s), (remote) up to 30 days; subcutaneous cardiac rhythm monitor system, including analysis of recorded heart rhythm data, analysis, review(s) and report(s) by a physician or other qualified health care professional | 25 | $1,389 |
| Screening for depression is documented as negative, a follow-up plan is not required | 26 | $0 |
| 2024 | 551 | 5 | 46 | $44,847 |
| 2023 | 628 | 8 | 46 | $48,880 |
| 2022 | 351 | 2 | 41 | $31,865 |
| 2021 | 419 | 2 | 38 | $53,142 |
| 2020 | 277 | 3 | 27 | $31,383 |
| 2019 | 322 | 2 | 31 | $22,395 |
| 2018 | 324 | 3 | 41 | $24,312 |
See the largest Medicaid services in earlier years
2023
| Long return visit (40+ min) | 239 | $28,887 |
| Clinic visit/encounter, all-inclusive | 24 | $9,683 |
| Return visit (30+ min) | 47 | $4,073 |
| Interrogation device evaluation(s) (remote), up to 90 days; single, dual, or multiple lead pacemaker system, leadless pacemaker system, or implantable defibrillator system, remote data acquisition(s), receipt of transmissions and technician review, technical support and distribution of results | 159 | $2,671 |
| Interrogation device evaluation(s) (remote), up to 90 days; single, dual, or multiple lead implantable defibrillator system with interim analysis, review(s) and report(s) by a physician or other qualified health care professional | 59 | $1,528 |
| Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and technician review, technical support and distribution of results | 44 | $1,069 |
| Interrogation device evaluation(s), (remote) up to 30 days; subcutaneous cardiac rhythm monitor system, including analysis of recorded heart rhythm data, analysis, review(s) and report(s) by a physician or other qualified health care professional | 44 | $969 |
| Screening for depression is documented as negative, a follow-up plan is not required | 12 | $0 |
2022
| Return visit (30+ min) | 338 | $31,616 |
| Interrogation device evaluation(s) (remote), up to 90 days; single, dual, or multiple lead pacemaker system, leadless pacemaker system, or implantable defibrillator system, remote data acquisition(s), receipt of transmissions and technician review, technical support and distribution of results | 13 | $249 |
2021
| Return visit (30+ min) | 356 | $38,003 |
| Clinic visit/encounter, all-inclusive | 63 | $15,139 |
2020
| Return visit (30+ min) | 194 | $16,737 |
| Clinic visit/encounter, all-inclusive | 53 | $12,732 |
| Short return visit (20+ min) | 30 | $1,914 |
2019
| Return visit (30+ min) | 269 | $21,736 |
| Electrocardiogram, routine ECG with at least 12 leads; with interpretation and report | 53 | $659 |
2018
| Return visit (30+ min) | 298 | $23,337 |
| Short return visit (20+ min) | 12 | $766 |
| Electrocardiogram, routine ECG with at least 12 leads; with interpretation and report | 14 | $208 |
Drugs they prescribed that Part D paid
$381,596
Pharmacies billed $381,596 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 950) in 2024. At or below the middle of the specialty; the typical clinical cardiac electrophysiology clinician is at 0%.
660 generic and 290 brand-name prescriptions · $381,596 in drug cost · 14 antibiotic prescriptions to 14 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Eliquis | 206 | $250,078 | $1,214 |
| Xarelto | 53 | $78,531 | $1,482 |
| Multaq | 13 | $27,242 | $2,096 |
| Sotalol | 57 | $1,818 | $32 |
| Amiodarone | 81 | $1,394 | $17 |
See all 20 drugs
| Eliquis | 206 | $250,078 | $1,214 |
| Xarelto | 53 | $78,531 | $1,482 |
| Multaq | 13 | $27,242 | $2,096 |
| Sotalol | 57 | $1,818 | $32 |
| Amiodarone | 81 | $1,394 | $17 |
| Metoprolol | 116 | $1,355 | $12 |
| Mexiletine | 12 | $1,319 | $110 |
| Diltiazem 24hr Er (Cd) | 18 | $870 | $48 |
| Flecainide Acetate | 25 | $628 | $25 |
| Carvedilol | 51 | $353 | $7 |
| Warfarin | 28 | $271 | $10 |
| Metoprolol | 45 | $253 | $6 |
| Sucralfate | 27 | $240 | $9 |
| Pantoprazole | 29 | $133 | $5 |
| Clopidogrel | 12 | $102 | $9 |
| Amlodipine Besylate | 14 | $100 | $7 |
| Furosemide | 18 | $83 | $5 |
| Atorvastatin | 12 | $73 | $6 |
| Losartan | 11 | $59 | $5 |
| Cephalexin | 13 | $48 | $4 |
Year by year
| 2024 | 950 | 262 | 0% (0) | 31% | $381,596 |
| 2023 | 1,021 | 255 | 0% (0) | 34% | $479,655 |
| 2022 | 1,155 | 263 | None | 36% | $524,447 |
| 2021 | 1,026 | 260 | 0% (0) | 36% | $396,573 |
| 2020 | 944 | 221 | None | 40% | $375,591 |
| 2019 | 806 | 199 | None | 35% | $286,698 |
| 2018 | 834 | 182 | None | 37% | $254,282 |
| 2017 | 903 | 183 | None | 37% | $212,053 |
| 2016 | 586 | 149 | 2% (13) | 34% | $104,561 |
| 2015 | 95 | 42 | None | 32% | $8,378 |
| 2014 | 194 | 23 | None | 18% | $8,623 |
| 2013 | 209 | 23 | 0% (0) | 11% | $5,222 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 17 drugs
| Eliquis | 217 | $278,302 | $1,282 |
| Xarelto | 72 | $104,498 | $1,451 |
| Multaq | 23 | $40,316 | $1,753 |
| Metoprolol | 133 | $3,166 | $24 |
| Sotalol | 63 | $2,041 | $32 |
| Amiodarone | 68 | $1,716 | $25 |
| Flecainide Acetate | 19 | $1,254 | $66 |
| Diltiazem 24hr Er (Cd) | 19 | $901 | $47 |
| Warfarin | 41 | $697 | $17 |
| Metoprolol | 52 | $687 | $13 |
| Carvedilol | 43 | $531 | $12 |
| Sucralfate | 29 | $522 | $18 |
| Pantoprazole | 26 | $312 | $12 |
| Losartan | 15 | $288 | $19 |
| Clopidogrel | 18 | $251 | $14 |
| Amlodipine Besylate | 12 | $177 | $15 |
| Lisinopril | 14 | $168 | $12 |
2022: 19 drugs
| Eliquis | 239 | $290,853 | $1,217 |
| Xarelto | 83 | $106,981 | $1,289 |
| Multaq | 30 | $48,292 | $1,610 |
| Pradaxa | 13 | $12,011 | $924 |
| Metoprolol | 137 | $2,867 | $21 |
| Mexiletine | 14 | $2,593 | $185 |
| Flecainide Acetate | 21 | $2,289 | $109 |
| Diltiazem 24hr Er (Cd) | 30 | $2,273 | $76 |
| Amiodarone | 71 | $1,647 | $23 |
| Sotalol | 62 | $1,589 | $26 |
| Metoprolol | 63 | $971 | $15 |
| Carvedilol | 45 | $962 | $21 |
| Warfarin | 36 | $740 | $21 |
| Losartan | 20 | $326 | $16 |
| Lisinopril | 31 | $216 | $7 |
| Clopidogrel | 13 | $168 | $13 |
| Atorvastatin | 16 | $100 | $6 |
| Furosemide | 15 | $92 | $6 |
| Hydrochlorothiazide | 11 | $35 | $3 |
2021: 18 drugs
| Eliquis | 205 | $205,810 | $1,004 |
| Xarelto | 86 | $98,992 | $1,151 |
| Multaq | 25 | $42,804 | $1,712 |
| Corlanor | 12 | $12,508 | $1,042 |
| Pradaxa | 11 | $9,002 | $818 |
| Metoprolol | 101 | $2,732 | $27 |
| Flecainide Acetate | 20 | $2,314 | $116 |
| Sotalol | 41 | $1,557 | $38 |
| Amiodarone | 56 | $1,509 | $27 |
| Metoprolol | 75 | $960 | $13 |
| Diltiazem 24hr Er (Cd) | 19 | $953 | $50 |
| Carvedilol | 46 | $815 | $18 |
| Warfarin | 37 | $695 | $19 |
| Hydrochlorothiazide | 20 | $250 | $12 |
| Atorvastatin | 31 | $216 | $7 |
| Benazepril | 17 | $177 | $10 |
| Pantoprazole | 13 | $171 | $13 |
| Furosemide | 13 | $142 | $11 |
2020: 17 drugs
| Eliquis | 185 | $180,345 | $975 |
| Xarelto | 87 | $94,614 | $1,088 |
| Multaq | 37 | $43,293 | $1,170 |
| Corlanor | 21 | $16,567 | $789 |
| Metoprolol | 91 | $3,031 | $33 |
| Sotalol | 40 | $2,968 | $74 |
| Flecainide Acetate | 31 | $2,948 | $95 |
| Mexiletine | 20 | $2,682 | $134 |
| Amiodarone | 46 | $1,348 | $29 |
| Metoprolol | 69 | $803 | $12 |
| Carvedilol | 45 | $615 | $14 |
| Warfarin | 31 | $564 | $18 |
| Atorvastatin | 19 | $303 | $16 |
| Pantoprazole | 12 | $221 | $18 |
| Lisinopril | 23 | $198 | $9 |
| Amlodipine Besylate | 14 | $158 | $11 |
| Furosemide | 17 | $129 | $8 |
2019: 18 drugs
| Eliquis | 118 | $112,055 | $950 |
| Xarelto | 84 | $82,807 | $986 |
| Multaq | 31 | $38,590 | $1,245 |
| Corlanor | 17 | $14,104 | $830 |
| Pradaxa | 15 | $10,024 | $668 |
| Amiodarone | 52 | $3,865 | $74 |
| Metoprolol | 103 | $3,543 | $34 |
| Flecainide Acetate | 26 | $2,757 | $106 |
| Sotalol | 39 | $2,396 | $61 |
| Mexiletine | 15 | $2,159 | $144 |
| Carvedilol | 55 | $882 | $16 |
| Warfarin | 28 | $622 | $22 |
| Metoprolol | 32 | $373 | $12 |
| Pantoprazole | 13 | $318 | $24 |
| Amlodipine Besylate | 22 | $251 | $11 |
| Lisinopril | 11 | $177 | $16 |
| Gabapentin | 11 | $176 | $16 |
| Losartan | 12 | $118 | $10 |
2018: 21 drugs
| Eliquis | 107 | $96,052 | $898 |
| Xarelto | 76 | $65,046 | $856 |
| Multaq | 39 | $48,910 | $1,254 |
| Pradaxa | 21 | $8,889 | $423 |
| Metoprolol | 103 | $4,214 | $41 |
| Mexiletine | 18 | $4,197 | $233 |
| Sotalol | 45 | $2,575 | $57 |
| Bystolic | 12 | $2,373 | $198 |
| Flecainide Acetate | 18 | $1,875 | $104 |
| Amiodarone | 32 | $936 | $29 |
| Warfarin | 37 | $920 | $25 |
| Carvedilol | 37 | $645 | $17 |
| Diltiazem 24hr Er (Cd) | 17 | $589 | $35 |
| Cartia Xt | 11 | $545 | $50 |
| Pantoprazole | 34 | $490 | $14 |
| Atorvastatin | 21 | $375 | $18 |
| Clopidogrel | 15 | $326 | $22 |
| Sucralfate | 11 | $318 | $29 |
| Metoprolol | 28 | $215 | $8 |
| Amlodipine Besylate | 16 | $164 | $10 |
| Furosemide | 16 | $116 | $7 |
2017: 19 drugs
| Eliquis | 131 | $92,259 | $704 |
| Xarelto | 60 | $43,675 | $728 |
| Multaq | 42 | $30,331 | $722 |
| Mexiletine | 42 | $10,118 | $241 |
| Nexium | 12 | $4,097 | $341 |
| Brilinta | 11 | $3,732 | $339 |
| Metoprolol | 58 | $1,984 | $34 |
| Amiodarone | 38 | $1,257 | $33 |
| Warfarin | 71 | $1,093 | $15 |
| Sotalol | 30 | $773 | $26 |
| Metoprolol | 34 | $588 | $17 |
| Diltiazem 24hr Er | 21 | $547 | $26 |
| Potassium Chloride | 13 | $393 | $30 |
| Atorvastatin | 35 | $384 | $11 |
| Carvedilol | 53 | $345 | $7 |
| Pantoprazole | 28 | $342 | $12 |
| Amlodipine Besylate | 17 | $95 | $6 |
| Furosemide | 26 | $90 | $3 |
| Benazepril | 15 | $38 | $3 |
2016: 18 drugs
| Eliquis | 91 | $50,503 | $555 |
| Multaq | 25 | $15,538 | $622 |
| Xarelto | 16 | $14,206 | $888 |
| Nexium | 11 | $5,374 | $489 |
| Metoprolol | 48 | $2,185 | $46 |
| Midodrine | 12 | $1,639 | $137 |
| Warfarin | 41 | $658 | $16 |
| Carvedilol | 57 | $611 | $11 |
| Flecainide Acetate | 14 | $387 | $28 |
| Sotalol | 15 | $359 | $24 |
| Doxycycline Hyclate | 17 | $323 | $19 |
| Losartan | 17 | $312 | $18 |
| Amiodarone | 14 | $222 | $16 |
| Metoprolol | 28 | $199 | $7 |
| Potassium Chloride | 11 | $194 | $18 |
| Furosemide | 20 | $92 | $5 |
| Amlodipine Besylate | 11 | $75 | $7 |
| Lisinopril | 14 | $59 | $4 |
2015: 1 drug
| Carvedilol | 13 | $135 | $10 |
2014: 8 drugs
| Xarelto | 11 | $3,189 | $290 |
| Nadolol | 13 | $757 | $58 |
| Atorvastatin | 21 | $634 | $30 |
| Clopidogrel | 12 | $303 | $25 |
| Metoprolol | 29 | $174 | $6 |
| Isosorbide Mononitrate Er | 11 | $132 | $12 |
| Lisinopril | 18 | $76 | $4 |
| Furosemide | 12 | $33 | $3 |
2013: 6 drugs
| Atorvastatin | 28 | $588 | $21 |
| Metoprolol | 43 | $301 | $7 |
| Lovastatin | 13 | $251 | $19 |
| Furosemide | 16 | $74 | $5 |
| Lisinopril | 15 | $66 | $4 |
| Amlodipine Besylate | 13 | $54 | $4 |
Money from drug and device companies
$488 in 2025
| 2025 | 5 | 14 | None | $488 |
| 2024 | 13 | 106 | $6,300 | $10,887 |
| 2023 | 10 | 58 | $6,300 | $7,631 |
| 2022 | 8 | 33 | None | $2,895 |
| 2021 | 6 | 24 | $1,500 | $1,990 |
| 2020 | 3 | 7 | None | $156 |
| 2019 | 3 | 6 | None | $143 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Boston Scientific | Farapulse | $312 | 7 payments
|
| Medtronic | Micra | $59 | 3 payments
|
| Biosense Webster | Carto 3 | $50 | 2 payments
|
| AtriCure | Epi-Sense Guided Coagulation System With Visitrax | $41 | 1 payment
|
| Abbott Laboratories | Amplatzer Amulet | $26 | 1 payment
|
See all 14 published payments
| Boston Scientific | Meals · 2025-10-31 | General - Ep | $55 |
| Boston Scientific | Meals · 2025-09-30 | Farapulse | $52 |
| Boston Scientific | Meals · 2025-07-02 | Farapulse | $42 |
| Boston Scientific | Meals · 2025-06-10 | Farapulse | $47 |
| Boston Scientific | Meals · 2025-05-23 | Farapulse | $47 |
| Boston Scientific | Meals · 2025-04-23 | Farapulse | $58 |
| Medtronic | Meals · 2025-03-27 | Micra | $18 |
| Biosense Webster | Meals · 2025-03-19 | Carto 3 | $27 |
| Boston Scientific | Meals · 2025-03-13 | Accolade Sr | $12 |
| Medtronic | Meals · 2025-03-12 | Micra | $22 |
| Medtronic | Meals · 2025-02-05 | Micra | $19 |
| Abbott Laboratories | Meals · 2025-01-29 | Amplatzer Amulet | $26 |
| Biosense Webster | Meals · 2025-01-24 | Carto 3 | $22 |
| AtriCure | Meals · 2025-01-06 | Epi-Sense Guided Coagulation System With Visitrax | $41 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $10,887
| Medtronic | Micra | $6,101 | 26 payments
|
| Medical Device Business Services | Carto 3 | $2,250 | 3 payments
|
| Biosense Webster | Carto 3 | $879 | 43 payments
|
| Philips North America | (Bs2) Lm Undivided | $814 | 6 payments
|
| Boston Scientific | Emblem Mri S-Icd | $429 | 10 payments
|
| Abbott Laboratories | Aveir | $177 | 6 payments
|
| Pfizer | Eliquis | $103 | 5 payments
|
| Kiniksa Pharmaceuticals International plc | Arcalyst | $41 | 2 payments
|
| Sanofi-Aventis U.S. | Multaq | $28 | 1 payment
|
| Cordis US | Mynx Venous Vcd | $24 | 1 payment
|
| Novo Nordisk | Rybelsus | $19 | 1 payment
|
| AstraZeneca Pharmaceuticals LP | Farxiga | $15 | 1 payment
|
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | Lifevest | $8 | 1 payment
|
2023: $7,631
| Medical Device Business Services | Carto 3 | $6,300 | 4 payments
|
| Medtronic | Micra | $467 | 13 payments
|
| Biosense Webster | Carto 3 | $389 | 18 payments
|
| E.R. Squibb & Sons L.L.C. | Eliquis | $168 | 11 payments
|
| Boston Scientific | Watchman Flx | $121 | 3 payments
|
| iRhythm Technologies | Zio Xt Patch | $72 | 4 payments
|
| Atricure | Epi-Sense Guided Coagulation System With Visitrax | $49 | 2 payments
|
| CardioFocus | Heartlight System | $27 | 1 payment
|
| Abbott Laboratories | Mitraclip | $23 | 1 payment
|
| Philips Electronics North America | (9124) Lm Undivided | $16 | 1 payment
|
2022: $2,895
| Abbott Laboratories | Aveir | $2,348 | 10 payments
|
| Medtronic | Micra | $213 | 10 payments
|
| Boston Scientific | Emblem Mri S-Icd | $169 | 5 payments
|
| Biosense Webster | Octaray Mapping Catheter | $72 | 3 payments
|
| AtriCure | Epi-Sense Guided Coagulation System With Visitrax | $38 | 2 payments
|
| Biotronik | Biomonitor | $20 | 1 payment
|
| Novartis Pharmaceuticals | Entresto | $18 | 1 payment
|
| AngioDynamics | Alphavac | $17 | 1 payment
|
2021: $1,990
| Medtronic | Selectsecure | $1,569 | 8 payments
|
| Biosense Webster | Carto 3 | $321 | 10 payments
|
| Boston Scientific | Watchman | $33 | 1 payment
|
| Atricure | Epi-Sense Guided Coagulation System With Visitrax | $28 | 2 payments
|
| Bard Peripheral Vascular | Lifestent | $27 | 2 payments
|
| Philips Electronics North America | (9124) Lm Undivided | $12 | 1 payment
|
2020: $156
| Abbott Laboratories | Ensite Cardiac Mapping System | $75 | 4 payments
|
| Boston Scientific | Latitude | $54 | 2 payments
|
| Medtronic Vascular | Reveal Linq | $28 | 1 payment
|
2019: $143
| Biosense Webster | Carto 3 System | $74 | 2 payments
|
| Boston Scientific | Labsystem Pro | $41 | 2 payments
|
| Abbott Laboratories | Assurity Pacemaker | $29 | 2 payments
|
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 85.2 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1073778726
- Licence
- CA A127103California A127103: Current · expires 2027-04-30
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 207RC0001X (207RC0001X); Internal medicine (207R00000X); Cardiology (207RC0000X)
- Mailing address
- 7974 Uw Health Ct, Middleton, WI, 53562
- NPI first listed
- 2008-07-22
- NPI last updated
- 2025-08-27
- NPI record certified
- 2025-08-27
This is when the NPI record was last certified, not a medical board exam.
This office lists an electronic records connection.